These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22930681)

  • 1. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
    Lee WJ; Kang MH; Seong M; Cho HY
    Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
    Wen J; Jiang Y; Zheng X; Zhou Y
    Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
    Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
    Lim JW
    Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
    Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
    Kunikata H; Shimura M; Nakazawa T; Sonoda KH; Yoshimura T; Ishibashi T; Nishida K
    Acta Ophthalmol; 2012 Mar; 90(2):162-7. PubMed ID: 20456252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of inflammatory factors with macular edema in branch retinal vein occlusion.
    Noma H; Mimura T; Eguchi S
    JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring ocular drug therapy by analysis of aqueous samples.
    Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
    Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1122-8. PubMed ID: 25634982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
    Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
    Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of electroretinographic parameters and inflammatory factors in branch retinal vein occlusion with macular oedema.
    Noma H; Funatsu H; Mimura T
    Br J Ophthalmol; 2012 Dec; 96(12):1489-93. PubMed ID: 23077221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.
    Funk M; Kriechbaum K; Prager F; Benesch T; Georgopoulos M; Zlabinger GJ; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1025-32. PubMed ID: 19060280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment.
    Kaneda S; Miyazaki D; Sasaki S; Yakura K; Terasaka Y; Miyake K; Ikeda Y; Funakoshi T; Baba T; Yamasaki A; Inoue Y
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):2982-8. PubMed ID: 21273540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
    Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
    Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
    Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
    Kim JH; Shin JP; Kim IT; Park DH
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.